Skip to main content

Peer Review reports

From: Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota

Original Submission
23 Dec 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
18 Feb 2022 Reviewed Reviewer Report - Yasuki Higashimura
24 Feb 2022 Reviewed Reviewer Report
2 Mar 2022 Reviewed Reviewer Report
8 Mar 2022 Author responded Author comments - Qinghua Yao
Resubmission - Version 4
8 Mar 2022 Submitted Manuscript version 4
12 Mar 2022 Author responded Author comments - Qinghua Yao
Resubmission - Version 5
12 Mar 2022 Submitted Manuscript version 5
16 Mar 2022 Author responded Author comments - Qinghua Yao
Resubmission - Version 6
16 Mar 2022 Submitted Manuscript version 6
18 Mar 2022 Author responded Author comments - Qinghua Yao
Resubmission - Version 7
18 Mar 2022 Submitted Manuscript version 7
23 Mar 2022 Reviewed Reviewer Report - Yasuki Higashimura
30 Mar 2022 Reviewed Reviewer Report
15 Apr 2022 Reviewed Reviewer Report
19 Apr 2022 Author responded Author comments - Qinghua Yao
Resubmission - Version 8
19 Apr 2022 Submitted Manuscript version 8
22 Apr 2022 Reviewed Reviewer Report - Yasuki Higashimura
2 May 2022 Reviewed Reviewer Report
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
4 May 2022 Editorially accepted
20 May 2022 Article published 10.1186/s12885-022-09635-9

You can find further information about peer review here.

Back to article page